ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 230

Increased Prevalence of Coronary Artery Disease in Patients with Chest Pain and Seropositive Rheumatoid Arthritis: An Analysis from a Clinical Computed Tomography-Based Large-Scale Population Cohort

Andreas Bugge Tingaard1, Annette de Thurah2, Ina Trolle Andersen3, Anders Hammerich Riis3, Josephine Therkildsen4, Ellen-Margrethe Hauge5 and Morten Böttcher4, 1Department of Cardiology, Regional Hospital of Herning, Herning, Denmark, 2Department of Rheumatology,, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus, Denmark, 3Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark, 4Cardiology, Regional Hospital of Herning, Herning, Denmark, 5Department of Rheumatology, Aarhus University Hospital, Aarhus, Aarhus, Denmark

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Computed tomography (CT), coronary artery disease, population studies and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Epidemiology and Public Health Poster I: Rheumatoid Arthritis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Inflammation seems to play a central role in the development of atherosclerosis and inflammatory diseases seem to promote progression of coronary artery disease (CAD). Rheumatoid arthritis (RA) is associated with increased mortality, and evidence exists of a strong association between RA and premature cardiac events. However, knowledge of the severity and pattern of coronary artery calcifications in RA patients is still sparse. The aim of this study was to examine the prevalence and severity of CAD in RA patients from a large-scale cohort with chest pain referred for CAD rule out.

Methods: This was a cross sectional study in 39,534 patients from the Western Denmark Heart Registry. For each individual, data included cardiac CTs (CCT) with a registration of up to 40 variables including level of stenosis and calcification. RA patients were identified through linkage with the Danish National Patient Registry. All analyses were performed for overall RA and the serological subtypes: ‘sero-positive RA’ and ‘other RA’. In the studied region, RA-flares are controlled through escalation of disease modifying drugs and intra-articular or intramuscular glucocorticoid injections (GCI). The number of times a patient had received GCIs 3 years prior to the CCT was used as a surrogate marker for disease activity. The prevalence of having a coronary artery calcium score (CACS) > 0 among RA and non-RA patients was assessed by estimating odds ratios (OR) with [95% CI], adjusted for gender, age, Charlsons co-morbidity index, hypertension, lipid-lowing treatment, body mass index and smoking status.

Results: A total of 337 (0.9%) patients with RA were identified; 268 (79.5%) being sero-positive. Women accounted for 73.9% of the RA patients compared to 54.4% of the non-RA patients. Non-obstructive CAD was present in 35.6% of the RA patients vs. 31.7% of the non-RA patients, and 15.4% of the RA patients had a CACS > 400 vs. 10.1% in non-RA patients. OR for having a CACS > 0 was 1.17 [0.91-1.50] 95% CI for overall RA, 1.33 [1.00-1.77] for sero-positive RA and 0.72 [0.42-1.24] for other-RA. Patients who had received >1 GCI 3 years prior to the CCT had an OR at 1.49 [0.99-2.27] for having CACS > 0.

Conclusion: Based on data from a large CCT database, coronary artery calcifications are more frequent in RA patients with seropositive disease and high disease activity RA. In particular, the occurrence of severe calcifications is more frequent. These findings support the hypothesis that inflammatory disease may accelerate the atherosclerotic process leading to increased coronary artery calcification and risk of cardiac events.


Disclosure: A. Bugge Tingaard, None; A. de Thurah, None; I. Trolle Andersen, None; A. Hammerich Riis, None; J. Therkildsen, None; E. M. Hauge, None; M. Böttcher, None.

To cite this abstract in AMA style:

Bugge Tingaard A, de Thurah A, Trolle Andersen I, Hammerich Riis A, Therkildsen J, Hauge EM, Böttcher M. Increased Prevalence of Coronary Artery Disease in Patients with Chest Pain and Seropositive Rheumatoid Arthritis: An Analysis from a Clinical Computed Tomography-Based Large-Scale Population Cohort [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/increased-prevalence-of-coronary-artery-disease-in-patients-with-chest-pain-and-seropositive-rheumatoid-arthritis-an-analysis-from-a-clinical-computed-tomography-based-large-scale-population-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-prevalence-of-coronary-artery-disease-in-patients-with-chest-pain-and-seropositive-rheumatoid-arthritis-an-analysis-from-a-clinical-computed-tomography-based-large-scale-population-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology